Andra Ap Fonden Abiomed Inc Transaction History

Andra Ap Fonden

$6.64 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $848,715 - $1.06 Million	-3,500 Reduced 12.32%	24,900 $6.12 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $426,987 - $643,416	1,900 Added 7.17%	28,400 $7.03 Million
Q4 2021 Feb 15, 2022	BUY	$300.63 - $371.35 $1.41 Million - $1.75 Million	4,700 Added 21.56%	26,500 $9.52 Million
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $310,190 - $376,200	1,000 Added 4.81%	21,800 $7.1 Million
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $1.81 Million - $2.42 Million	-6,900 Reduced 24.91%	20,800 $6.49 Million
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $1.29 Million - $1.6 Million	4,500 Added 19.4%	27,700 $8.83 Million
Q4 2020 Feb 12, 2021	SELL	$251.88 - $324.2 $403,008 - $518,720	-1,600 Reduced 6.45%	23,200 $7.52 Million
Q3 2020 Nov 12, 2020	BUY	$255.22 - $317.0 $1.89 Million - $2.35 Million	7,400 Added 42.53%	24,800 $6.87 Million
Q2 2020 Aug 06, 2020	SELL	$141.4 - $257.09 $692,860 - $1.26 Million	-4,900 Reduced 21.97%	17,400 $4.2 Million
Q1 2020 May 13, 2020	BUY	$130.51 - $196.01 $626,448 - $940,848	4,800 Added 27.43%	22,300 $3.24 Million
Q4 2019 Feb 10, 2020	BUY	$159.31 - $223.54 $1.91 Million - $2.68 Million	12,000 Added 218.18%	17,500 $2.99 Million
Q3 2019 Nov 19, 2019	SELL	$175.89 - $279.23 $175,890 - $279,230	-1,000 Reduced 15.38%	5,500 $978,000
Q1 2019 May 14, 2019	SELL	$276.39 - $362.25 $773,892 - $1.01 Million	-2,800 Reduced 30.11%	6,500 $1.86 Million
Q3 2018 Oct 16, 2018	BUY	$354.53 - $449.75 $460,888 - $584,675	1,300 Added 16.25%	9,300 $4.18 Million
Q2 2018 Aug 17, 2018	BUY	$278.07 - $446.21 $2.22 Million - $3.57 Million	8,000 New	8,000 $3.27 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account